| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
678,200
|
825,502
|
968,231
|
1,264,885
| | Cost of Revenue | 595,368 | 710,573 | 809,074 | 1,023,122 | | |
Gross Profit
|
82,832
|
114,929
|
159,157
|
241,763
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 17,430 | 31,300 | 87,962 | (66,265) |
|
Non Recurring | 20,482 |
-
| 230,632 | (2,015) |
|
Others | 100,201 | 116,058 | 123,208 | 139,890 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(55,281)
|
(32,429)
|
(282,645)
|
170,153
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,216 | 2,836 | (2,716) | 1,459 |
|
Earnings Before Interest And Taxes | (54,065) | (29,593) | (285,361) | 171,612 |
|
Interest Expense | 94,743 | 95,087 | 88,416 | 75,710 |
|
Income Before Tax | (148,808) | (124,680) | (373,777) | 95,902 |
|
Income Tax Expense | (54,190) | (54,631) | (78,354) | 27,611 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (94,618) | (70,049) | (319,091) | 68,023 | |
|
Non-recurring Events |
|
Discontinued Operations | 22,412 |
-
|
-
| (22,540) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(72,206)
|
(70,049)
|
(295,423)
|
45,751
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(72,206)
|
(70,049)
|
(295,423)
|
45,751
|
|
0.05 (1.24%) 9:02AM EDT - Nasdaq Real Time Price